Bold Therapeutics

Vancouver, Canada · Founded 2018 · Privately Held (backing)

Developer of novel metallotherapeutics metal-based small molecules designed for the treatment of cancer. Bold Therapeutics is based in Vancouver, Canada and was founded in 2018. Its last known valuation is $140 million. It has raised $25 million across 1 recorded round; the latest was a $5.5 million early-stage round in Jul 2018.

Last price · $/share
—
Implied valuation
$140.0M
Total raised
$25.0M
Last round
Early Stage VC
Jul 2018
How much has Bold Therapeutics raised?
$25.0Macross 1 recorded rounds · Jul 2018 – Jul 2018

Most recently, Bold Therapeutics raised $5.5M in its Early Stage VC (Jul 2018).

Free account
More of Bold Therapeutics with a free account
  • ·Watch Bold Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Bold Therapeutics round by round

1 rounds
Jul 2018Early Stage VC$5.5MSEC filing▮
48 investors participated

How much has Bold Therapeutics raised?

Bold Therapeutics has raised $25 million in total; 1 of its rounds is on record. The largest on record was a $5.5 million early-stage round in Jul 2018.

Bold Therapeutics has filed 1 Form D with the SEC, most recently in Feb 2021 ($5.5 million sold to 48 investors).

Bold Therapeutics investors

4 investors are on record for Bold Therapeutics, including Life Sciences BC, Gaston Capital, National Research Council Canada and Tampa Bay Technology Incubator. The early-stage round in Jul 2018 drew 48 investors.

For fundraisers
Raising for a company like Bold Therapeutics?

4 investors have backed Bold Therapeutics.

See all 4 investors →

Frequently asked about Bold Therapeutics

How much has Bold Therapeutics raised?
Bold Therapeutics has raised $25.0M in total across 1 recorded funding rounds.
When was Bold Therapeutics's last funding round?
Bold Therapeutics's most recent recorded round was Early Stage VC in Jul 2018, raising $5.5M.